Is it good clinical judgment or selection bias? Maurie Markman Editor’s Commentary Pages: 377 - 378
Assessing the quality of clinical trials: Can it be done? Charles L. BennettJared R. Adams Clinical Trials Report Pages: 387 - 388
Acknowledgment of uncertainty: A fundamental means to ensure scientific and ethical validity in clinical research Benjamin Djulbegovic OriginalPaper Pages: 389 - 395
Conflict of interest in industrysponsored economic evaluations: Real or imagined? Marco BarbieriMichael F. Drummond OriginalPaper Pages: 410 - 413
The role of resection for patients with renal carcinoma Robert C. FlaniganPaul M. Yonover OriginalPaper Pages: 424 - 432
Allogeneic stem-cell transplantation in renal-cell carcinoma Brandon M. Hayes-LattinRichard T. MaziarzTomasz M. Beer OriginalPaper Pages: 433 - 437
Gene therapy for prostate cancer Jeffrey R. GingrichRavi D. ChauhanMitchell S. Steiner OriginalPaper Pages: 438 - 447
Complementary and alternative medicine in prostate cancer Judith S. JacobsonAnitha P. Chetty OriginalPaper Pages: 448 - 452
Combination therapy in hormone-refractory prostate cancer Daniel P. Petrylak Clinical Trials Report Pages: 453 - 453
